15-40899282-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_020857.3(VPS18):c.464G>A(p.Ser155Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,614,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020857.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS18 | NM_020857.3 | c.464G>A | p.Ser155Asn | missense_variant | 4/5 | ENST00000220509.10 | NP_065908.1 | |
VPS18 | XM_011521843.3 | c.248G>A | p.Ser83Asn | missense_variant | 3/4 | XP_011520145.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS18 | ENST00000220509.10 | c.464G>A | p.Ser155Asn | missense_variant | 4/5 | 1 | NM_020857.3 | ENSP00000220509 | P1 | |
VPS18 | ENST00000558474.1 | c.325+284G>A | intron_variant | 3 | ENSP00000453555 | |||||
VPS18 | ENST00000558855.5 | c.*225G>A | 3_prime_UTR_variant, NMD_transcript_variant | 5/5 | 5 | ENSP00000453265 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152250Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000139 AC: 35AN: 251294Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135824
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461862Hom.: 0 Cov.: 32 AF XY: 0.0000234 AC XY: 17AN XY: 727230
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152250Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 03, 2022 | The c.464G>A (p.S155N) alteration is located in exon 4 (coding exon 4) of the VPS18 gene. This alteration results from a G to A substitution at nucleotide position 464, causing the serine (S) at amino acid position 155 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at